FibroBiologics, Inc., a clinical-stage biotechnology company with a focus on developing therapeutics for chronic diseases, has announced that research scientist Simon Gebremeskel will present a ...

FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 240+ patents issued and pending with a focus on the development of therapeutics and potential cures ...

ThymUS brings together international researchers working on thymus and T-cell biology. The abstract entitled “A rapid and scalable thymus organoid development method for generating functional T cells” ...

HOUSTON, April 29, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 240+ patents issued and pending with a focus on ...

UbiVac’s DPV-001 induces Development of 1st in-patient generated TCR to Non-Small Cell Lung Cancer’s “Dark Matter” – Targets cancer without apparent toxicity ...

The thymus gland is part of our lymphatic system. It’s involved in the development of a type of white blood cell called a T lymphocyte. These white blood cells are part of your immune system. They ...

More information: Kazuki Okuyama et al, A mutant BCL11B-N440K protein interferes with BCL11A function during T lymphocyte and neuronal development, Nature Immunology (2024). DOI: 10.1038/s41590 ...